Stock TRML TOURMALINE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Tourmaline Bio, Inc.

Equities

TRML

US89157D1054

Market Closed - Nasdaq
Other stock markets
 21:00:00 17/05/2024 BST 		5-day change 1st Jan Change
15.04 USD +0.27% Intraday chart for Tourmaline Bio, Inc. +3.72% -42.55%
05-16 Tourmaline Bio, Inc Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial CI
05-13 Tourmaline Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
12bb.YzGGkRlsURHQ_LiW8kc0U7gaKpnqEJiJYU2Y6zOKiDM.K3vN2nozFF-Vm8_eqxFOPe9bS9e7JPvsLR7in2vFsUU8a-_5dDkUdbzK4Q~269da8d6307b9bfc2657961064084fcf
  1. Stock Market
  2. Equities
  3. TRML Stock
  4. Charts Tourmaline Bio, Inc.
  5. News Chart